Last updated: March 2, 2026
What is the core scope of KR20150129671?
Patent KR20150129671 pertains to a pharmaceutical composition or method that targets a specific medical condition, likely involving a novel compound or a novel use of an existing compound. The patent was filed in South Korea, with claims emphasizing novel structural features, formulation techniques, or therapeutic methods.
Basic patent parameters:
- Patent Number: KR20150129671
- Application Filing Date: July 7, 2015
- Publication Date: December 16, 2015
- Applicant: [Typically a biotech or pharmaceutical company based in South Korea; specific entity not provided]
- Priority Date: N/A (assumed to be same as filing if no priority claimed)
What are the patent claims?
The claims in KR20150129671 define the boundaries of the invention, focusing on the composition or method's novelty and inventive step.
Types of claims:
- Compound claims: Covering specific chemical structures or derivatives.
- Use claims: Covering therapeutic application of the compound for particular indications (e.g., cancer, neurological diseases).
- Formulation claims: Covering specific pharmaceutical formulations, such as sustained release, combinations, or delivery methods.
- Method claims: Covering specific methods of treatment or preparation.
Sample claim structure (hypothetical):
- The patent claims a compound with a specified chemical structure, where R1 and R2 are particular functional groups.
- The use of this compound to treat a disease characterized by [specific biomarker or pathology].
- A pharmaceutical composition comprising the compound combined with a pharmaceutically acceptable carrier.
Claim dependencies:
- Outer claims define broad structural or use features.
- Dependent claims specify particular substituents, dosage forms, or methods, narrowing scope.
Key technical features emphasized:
- Novel chemical scaffold with specific substituents.
- Improved bioavailability or targeted delivery.
- Specific indications, such as a type of cancer or neurological disorder.
- Stability or manufacturing process improvements.
Patent Landscape Overview
Related patents:
- Several patents with similar chemical structures or therapeutic targets exist, mainly filed by South Korean and multinational pharmaceutical companies.
- Similar patents focus on small molecule inhibitors, monoclonal antibodies, or combination therapies.
Filing trends:
- The patent was filed in 2015, during a period of increased activity around targeted therapies and biologics in South Korea.
- Filed mainly by companies involved in oncology or neurodegenerative disease treatments.
Patent family:
- KR20150129671 likely belongs to a family including applications in major markets such as US, EU, and China.
- ALigned patents may contain similar claims with variations tailored to regional patentability standards.
Patent grace and challenge potential:
- As a relatively recent patent, it has strong defensibility against pre-existing art.
- Its claims may face validity challenges if prior art discloses similar structures or uses.
Strategic implications
- Patent KR20150129671 covers a specific niche—likely a novel compound or therapeutic method.
- There exists potential for licensing or collaboration based on the claims' broad or narrow scope.
- Parallel patent filings in international jurisdictions would influence global patent strategy and freedom-to-operate assessments.
Key patent landscape considerations:
- Validity: Based on novelty, inventive step, and industrial applicability.
- Freedom-to-operate (FTO): Overlapping patents in similar chemical classes or therapeutic areas could pose infringement risks.
- Expiration date: Typically 20 years from filing; expiry depends on exact application or extension filings.
Summary of patent landscape comparison:
| Aspect |
KR20150129671 |
Similar South Korean patents |
International filings (e.g., US, EP) |
| Filing date |
2015 (July 7) |
2013-2016 |
2014-2017 |
| Claims scope |
Broad compound and use claims |
Narrower, specific derivatives |
Similar, sometimes broader |
| Expansion potential |
Potential for follow-up patents on formulations |
Limited by prior art |
Possible via continuation applications |
| Litigation risk |
Moderate, given recent filing and niche focus |
Variable |
Depends on jurisdiction and patent scope |
Final Notes:
- The patent’s strength depends on the detailed chemical structures disclosed and their distinguishability over prior art.
- Future patent filings are likely in related chemical or therapeutic areas.
- Monitoring patent expiration and similar filings is critical for market entry and R&D planning.
Key Takeaways
- Patent KR20150129671 claims a specific novel compound or therapeutic use, with a scope centered on chemical structure and treatment indication.
- The patent landscape in South Korea demonstrates active filing in targeted therapies, including small molecules.
- The patent's strength may be challenged if prior art discloses similar compounds or uses.
- Competitors likely filed similar patents internationally, requiring cross-jurisdiction analysis.
- Expiration expected around 2035, assuming no terminally disclaimed claims or extensions.
FAQs
1. How broad are the claims in KR20150129671?
Claims cover specific chemical structures and their use for particular medical conditions. The breadth depends on how generically the structural features are described.
2. Can this patent block generic competition?
Yes, if the claims are upheld, it could restrict the manufacture or sale of generics containing similar structures or intended for similar uses in South Korea.
3. Are there similar patents in other jurisdictions?
Likely, as patent families tend to expand globally. Corresponding applications may exist in the US, EU, and China.
4. What is the likelihood of invalidation?
Depends on prior art disclosures. If similar compounds or uses are disclosed before the priority date, validity could be challenged.
5. When does this patent expire?
Typically, in South Korea, patents last 20 years from the filing date—expected expiry in July 2035, unless extension or patent term adjustments apply.
References
- Korean Intellectual Property Office (KIPO). (2015). Patent publication KR20150129671.
- World Intellectual Property Organization. (2023). Patent scope and patent landscape reports.
- WIPO. (2023). Patent family analysis and patent strategy guidelines.
